Key Takeaway: Telix Pharmaceuticals announced that Dr. Christian Behrenbruch, the Managing Director and Group CEO, will present at the Jefferies London Healthcare Conference 2023. The presentation is scheduled for November 15, 2023, from 4:00 to 4:30 PM GMT. A webcast of the event will be available for registration and on-demand viewing afterward.
Market Sentiment Analysis
POSITIVE FACTORS
Telix is actively engaging with investors at a prominent conference.
The presentation will provide insights into the company's future plans.
Webcast availability increases accessibility for interested participants.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
7%
average across 7 past catalysts
Lead asset
131I-IPA
Phase 1 · Neoplastic Disease
Full Press Release Details
Melbourne (Australia) | 9 November 2023
Telix today advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies London Healthcare Conference 2023.
The presentation will take place on Wednesday 15 November from 4:00 – 4:30pm GMT (11:00am EST / 3:00am AEDT, 16 November).